Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SGX:T14)
Singapore flag Singapore · Delayed Price · Currency is SGD · Price in USD
3.230
+0.060 (1.89%)
At close: Dec 5, 2025

Tianjin Pharmaceutical Da Ren Tang Group Corporation Company Description

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited engages in the research, development, processing, manufacturing, and sale of traditional Chinese medicine in China.

It provides pharmaceutical products for cardiovascular and cerebrovascular, skin wound repair, health preservation, respiratory, digestion, rheumatism and osteodynia, urological, gynecological and pediatric, ophthalmological, tumor, chronic, and other diseases, as well as tonic drugs.

The company was formerly known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited and changed its name to Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited in May 2022.

The company was founded in 1981 and is based in Tianjin, the People’s Republic of China.

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
CountryChina
Founded1981
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Employees4,619

Contact Details

Address:
Darentang Building
Tianjin, 300193
China
Phone86 22 2702 0598
Websitejydrt.com.cn

Stock Details

Ticker SymbolT14
ExchangeSingapore Exchange
Fiscal YearJanuary - December
Reporting CurrencyCNY
ISIN NumberCNE100000924
SIC Code2834